ng-nitroarginine methyl ester has been researched along with Vascular Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| D'Haese, PC; De Meyer, GRY; Fransen, P; Neven, E; Opdebeeck, B; Van den Bergh, G; Van den Branden, A; Verhulst, A | 1 |
| Chen, K; Lu, Y; Sun, Y; Wang, Q; Yang, C; Zhang, C | 1 |
| Imaizumi, Y; Kaneda, Y; Nagasawa, M; Nakagami, H; Nakajima, T; Nozato, Y; Rakugi, H; Takami, Y; Takeda, S; Takeshita, H; Takeya, Y; Wang, C; Yamamoto, K | 1 |
| Chen, M; Hou, Y; Li, B; Lin, Q; Qiu, W; Shi, Y; Zeng, S; Zhang, D; Zhou, H | 1 |
| Arranz, C; Caniffi, C; Elesgaray, R; Gobetto, MN; Juriol, LV; Mendes Garrido Abregú, F; Tomat, AL | 1 |
| Do, MH; Kim, SY; Lee, JH; Lim, Y; Parveen, A; Shim, SH | 1 |
| Capettini, LS; Cruz, JS; Gioda, CR; Lemos, VS | 1 |
| Asakura, M; Hirota, T; Kitakaze, M; Matsushita, A; Nakamura, T; Nonaka, A; Ohki, K | 1 |
| Majumdar, A; Nirwane, A; Pawar, V | 1 |
| Arvapalli, R; Asano, S; Blough, ER; Ma, B; Manne, ND; Nandyala, G; Rice, KM; Selvaraj, V | 1 |
| Beach, TG; Burciu, C; Davies, HA; Franco, DA; Guzman-Villanueva, D; Karamanova, N; Madine, J; Migrino, RQ; Serrano, G; Truran, S; Weissig, V | 1 |
| Fahim, M; Omanwar, S; Ravi, K | 1 |
| Bailón, E; Delpón, E; Duarte, J; Galindo, P; Gómez-Guzmán, M; Jiménez, R; Lopez-Sepulveda, R; O'Valle, F; Perez-Vizcaino, F; Quintela, AM; Romero, M; Sánchez, M; Zarzuelo, MJ | 1 |
| Chatziantoniou, C; Dussaule, JC; Guerrot, D; Mael-Ainin, M; Placier, S; Rondeau, E; Xu-Dubois, YC | 1 |
| Ai, J; Ban, X; Niu, H; Sun, L; Wang, N; Xu, Y; Yang, B; Yu, Y; Zhang, R; Zhao, R | 1 |
| Bleeke, T; Chen, X; Friedrich, S; Niroomand, F; Tiefenbacher, CP; Vahl, C | 1 |
| MacLeod, KM; McNeill, JH; Nagareddy, PR; Xia, Z | 1 |
| Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY | 1 |
| Ku, DD; Man, RY; Shi, Y; Vanhoutte, PM | 1 |
| Churg, A; Wright, JL | 1 |
| Greenhalgh, RM; Hicks, RC; Higman, DJ; Moss, J; Powell, JT | 1 |
| Andoh, TF; Bennett, WM; Gardner, MP | 1 |
| Fisher, D; Ischiropoulos, H; Ohnishi, ST; Thom, SR; Xu, YA | 1 |
| Booth, G; Lefer, DJ; Scalia, R | 1 |
| Arnal, JF; Darblade, B; Dinh-Xuan, AT; Pueyo, M; Rami, J | 1 |
| Artuso, A; Bouriquet, N; Casellas, D | 1 |
| Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH | 1 |
| Hoshino, T; Iwasaki, S; Mineta, H; Mizuta, K; Nagura, M; Umemura, K | 1 |
| Feng, L; Johnson, RJ; Kang, DH; Nakagawa, T | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Vascular Diseases
| Article | Year |
|---|---|
Endothelium-derived nitric oxide and vascular physiology and pathology.
Topics: Animals; Arginine; Arteriosclerosis; Blood Vessels; Caveolin 1; Caveolins; Cell Adhesion; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Humans; Hypertension; Hypertension, Pulmonary; Isoenzymes; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxidative Stress; Rabbits; Signal Transduction; Vascular Diseases; Vasodilation | 1999 |
28 other study(ies) available for ng-nitroarginine methyl ester and Vascular Diseases
| Article | Year |
|---|---|
Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats.
Topics: Animals; Calcinosis; Calcium; Disease Progression; Endothelial Cells; Male; NG-Nitroarginine Methyl Ester; Rats; Tunica Media; Vascular Calcification; Vascular Diseases; Warfarin | 2022 |
Capsaicin Alleviates Vascular Endothelial Dysfunction and Cardiomyopathy via TRPV1/eNOS Pathway in Diabetic Rats.
Topics: Animals; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endothelial Cells; Endothelium, Vascular; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Streptozocin; TRPV Cation Channels; Vascular Diseases | 2022 |
Novel pathophysiological roles of α-synuclein in age-related vascular endothelial dysfunction.
Topics: Acetylcholine; alpha-Synuclein; Animals; Endothelial Cells; Mice; Mice, Knockout; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Palmitic Acid; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sirtuin 1; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2022 |
Limosilactobacillus reuteri ameliorates preeclampsia in mice via improving gut dysbiosis and endothelial dysfunction.
Topics: Animals; Dysbiosis; Female; Humans; Inflammation; Limosilactobacillus reuteri; Mice; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Probiotics; Vascular Diseases | 2023 |
Developmental programming of vascular dysfunction by prenatal and postnatal zinc deficiency in male and female rats.
Topics: Acetylcholine; Angiotensin II; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Aorta, Thoracic; Calcium; Female; Lactation; Male; Malnutrition; Maternal Nutritional Physiological Phenomena; Micronutrients; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Oxidants; Oxidative Stress; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Systole; Vascular Diseases; Vasoconstrictor Agents; Zinc | 2018 |
Lespedeza cuneata protects the endothelial dysfunction via eNOS phosphorylation of PI3K/Akt signaling pathway in HUVECs.
Topics: Cell Survival; Chromones; Human Umbilical Vein Endothelial Cells; Humans; Lespedeza; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Diseases | 2018 |
Thiamine deficiency leads to reduced nitric oxide production and vascular dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta; Hydrazines; Indomethacin; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Rats; Rats, Wistar; Thiamine Deficiency; Vascular Diseases; Vasoconstriction; Vasodilation | 2014 |
The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats.
Topics: Acetylcholine; Animals; Arteries; Blood Pressure; Enzyme Inhibitors; Male; Milk; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Pulse Wave Analysis; Rats; Rats, Wistar; Vascular Diseases; Vasodilator Agents | 2014 |
Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Topics: Animals; Aorta, Thoracic; Arsenites; Benzimidazoles; Benzoates; Cardiovascular Agents; Cholesterol; Endothelium, Vascular; Fatty Acids, Omega-3; Glyburide; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Sodium Compounds; Telmisartan; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases; Vasodilation | 2015 |
Cecal inoculum peritonitis: An alternative model for sepsis vascular dysfunction study.
Topics: Acetylcholine; Animals; Cecum; Enzyme Inhibitors; KATP Channels; Large-Conductance Calcium-Activated Potassium Channels; Ligation; Lipopolysaccharides; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Peritonitis; Phenylephrine; Rats; Rats, Sprague-Dawley; Sepsis; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents | 2015 |
Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide.
Topics: Acetylcholine; Adipose Tissue; Amyloid beta-Peptides; Arterioles; Cholesterol; Endothelium, Vascular; Humans; In Vitro Techniques; Liposomes; Male; Meninges; Middle Aged; Nanoparticles; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Phosphatidic Acids; Phosphatidylcholines; Vascular Diseases; Vasodilation; Vasodilator Agents | 2016 |
Persistence of EDHF pathway and impairment of the nitric oxide pathway after chronic mercury chloride exposure in rats: mechanisms of endothelial dysfunction.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Biological Factors; Endothelium, Vascular; Environmental Pollutants; Female; Glyburide; In Vitro Techniques; Isoproterenol; Male; Malondialdehyde; Mercuric Chloride; Mercury; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Wistar; Vascular Diseases; Vasodilation; Vasodilator Agents | 2011 |
Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
Topics: Animals; Atherosclerosis; Blood Pressure; Catechin; Cyclooxygenase 2; Endothelium, Vascular; Hypertension; Hypertrophy; Inflammation; Inflammation Mediators; Kidney; Male; MAP Kinase Signaling System; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Phosphorylation; Phytotherapy; Plant Extracts; Prostaglandins; Proteinuria; Rats; Rats, Wistar; Up-Regulation; Vascular Diseases; Vasoconstriction | 2011 |
Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.
Topics: Animals; Biomarkers; Blood Pressure; Cell Adhesion Molecules; Disease Progression; Gene Expression Regulation; Humans; Hypertension; Kidney Diseases; Kidney Transplantation; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transplantation, Homologous; Vascular Diseases | 2012 |
Daming capsule restores endothelial dysfunction induced by high-fat diet.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Diet, High-Fat; Drugs, Chinese Herbal; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Hyperlipidemias; Hypolipidemic Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phytotherapy; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vascular Diseases; Vasoconstriction; Vasodilation | 2012 |
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fluvastatin; Histamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Lisinopril; Male; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Serotonin; Tetrazoles; Vascular Diseases; Vascular Resistance; Vasodilator Agents | 2004 |
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.
Topics: Amidines; Angiotensin II; Animals; Benzylamines; Blood Pressure; Blotting, Western; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Hemodynamics; Immunohistochemistry; Male; Methoxamine; Neurotensin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Vascular Diseases; Vasoconstrictor Agents | 2005 |
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases | 2005 |
Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats.
Topics: Acetylcholine; Animals; Biological Factors; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vasodilation | 2006 |
Short-term exposure to cigarette smoke induces endothelial dysfunction in small intrapulmonary arteries: analysis using guinea pig precision cut lung slices.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arteries; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Guinea Pigs; Lung; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nicotiana; Nitric Oxide Synthase Type III; Nitroprusside; Organ Culture Techniques; Pulmonary Circulation; Smoke; Vascular Diseases; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Blood Vessel Prosthesis; Bradykinin; Calcimycin; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; In Vitro Techniques; Indomethacin; Ischemia; Leg; Male; Microscopy, Electron; Middle Aged; NG-Nitroarginine Methyl Ester; Postoperative Complications; Saphenous Vein; Time Factors; Vascular Diseases; Vascular Surgical Procedures; Vasodilation | 1997 |
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1997 |
Pulmonary vascular stress from carbon monoxide.
Topics: Animals; Capillaries; Carbon Monoxide; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Hydrogen Peroxide; Kinetics; Leukocytes; Lung; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tyrosine; Vascular Diseases | 1999 |
Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide.
Topics: Animals; Aorta; Endothelial Growth Factors; Endothelium, Vascular; Inflammation; Intestines; Leukocytes; Lymphokines; Male; Mesentery; Mice; Mice, Mutant Strains; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Thrombin; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Venules | 1999 |
Nitric oxide and preglomerular vascular lesions in lyon spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Azo Compounds; Coloring Agents; Drug Combinations; Enzyme Inhibitors; Hydralazine; Hypertension; Kidney Glomerulus; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Diseases | 2000 |
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases | 2000 |
Role of nitric oxide in focal microcirculation disorder of guinea pig cochlea.
Topics: Animals; Cochlea; Cochlear Diseases; Enzyme Inhibitors; Guinea Pigs; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Photochemistry; Reactive Oxygen Species; Regional Blood Flow; Vascular Diseases | 2001 |
Nitric oxide modulates vascular disease in the remnant kidney model.
Topics: Animals; Arteries; Disease Progression; Endothelial Growth Factors; Enzyme Inhibitors; Kidney Glomerulus; Lymphokines; Male; Mice; Microcirculation; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Postoperative Period; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |